1102925

HCG Manavata Cancer Centre — FEI 3015050454

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 27, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Nashik (India)

Additional Details

Clinical BA/BE

Citations

IDCFRDescription
756021 CFR 312.60FD-1572, protocol compliance